| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Clinical Investigations |
1 Nuclear Medicine, Department of Clinical Physiopathology, University of Florence, Florence, Italy
2 Clinica Medica Generale e Cardiologia, University of Florence, Florence, Italy
3 Department of Cardiovascular Medicine, Don Gnocchi Foundation, IRCCS, Florence, Italy
Cardiac resynchronization therapy (CRT) by biventricular pacing is indicated in patients with severe heart failure and left bundle branch block who remain symptomatic despite optimal medical therapy. The relationship between baseline resting perfusion pattern and hemodynamic response to CRT has not been fully investigated. We tested the usefulness of perfusion gated SPECT for baseline evaluation and follow-up of these patients. Methods: In 20 patients, we performed gated SPECT before CRT and at the 3-mo follow up. Left ventricular (LV) ejection fraction (EF), end-diastolic (ED) and end-systolic (ES) volume indexes (VI), and wall motion score index (WMSI) were measured and compared with clinical outcome. Results: One patient died before follow-up. The 19 remaining patients were classified into 1 of 2 groups according to the presence (group A) or absence (group B) of a significant severe perfusion defect at baseline before CRT. At the 3-mo follow-up, 6 of 10 group A and 8 of 9 group B patients had an improvement in New York Heart Association class. In both groups, quality of life, 6-min walking distance, and WMSI significantly improved. In group A, no significant change was registered in LVEF, LVEDVI, or LVESVI. In group B, LVEF increased from 23.1% ± 8% to 27.1% ± 11% (P < 0.03) and LVEDVI and LVESVI decreased from 159 ± 70 mL to 135 ± 68 mL (P < 0.02) and from 127 ± 67 mL to 104 ± 65 mL (P < 0.01), respectively. Conclusion: Perfusion gated SPECT appears useful to characterize and follow up candidates for CRT. Despite clinical improvement, patients with severe resting perfusion defects do not show significant improvement in LVEF or reduction in LV volumes.
Key Words: heart failure • pacing • perfusion scintigraphy
This article has been cited by other articles:
|
|
 |
|
  M. Bertini, V. Delgado, D. W. den Uijl, G. Nucifora, A. C.T. Ng, R. J. van Bommel, C. J. W. Borleffs, G. Boriani, M. J. Schalij, and J. J. Bax Prediction of Cardiac Resynchronization Therapy Response: Value of Calibrated Integrated Backscatter Imaging Circ Cardiovasc Imaging, January 1, 2010; 3(1): 86 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Z. Khan, M. S. Virdee, S. P. Fynn, and D. P. Dutka Left ventricular lead placement in cardiac resynchronization therapy: where and how? Europace, May 1, 2009; 11(5): 554 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D'Andrea, P. Caso, R. Scarafile, L. Riegler, G. Salerno, F. Castaldo, R. Gravino, R. Cocchia, L. Del Viscovo, G. Limongelli, et al. Effects of global longitudinal strain and total scar burden on response to cardiac resynchronization therapy in patients with ischaemic dilated cardiomyopathy Eur J Heart Fail, January 1, 2009; 11(1): 58 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Henneman, E. E. van der Wall, C. Ypenburg, G. B. Bleeker, N. R. van de Veire, N. A. Marsan, J. Chen, E. V. Garcia, J. J.M. Westenberg, M. J. Schalij, et al. Nuclear Imaging in Cardiac Resynchronization Therapy J. Nucl. Med., December 1, 2007; 48(12): 2001 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Henneman, J. Chen, P. Dibbets-Schneider, M. P. Stokkel, G. B. Bleeker, C. Ypenburg, E. E. van der Wall, M. J. Schalij, E. V. Garcia, and J. J. Bax Can LV Dyssynchrony as Assessed with Phase Analysis on Gated Myocardial Perfusion SPECT Predict Response to CRT? J. Nucl. Med., July 1, 2007; 48(7): 1104 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ypenburg, M. J. Schalij, G. B. Bleeker, P. Steendijk, E. Boersma, P. Dibbets-Schneider, M. P. Stokkel, E. E. van der Wall, and J. J. Bax Extent of Viability to Predict Response to Cardiac Resynchronization Therapy in Ischemic Heart Failure Patients J. Nucl. Med., October 1, 2006; 47(10): 1565 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. D. Winter, N. V. de Veire, F. V. Heuverswijn, G. V. Pottelberge, T. C. Gillebert, and J. D. Sutter Relationship between QRS duration, left ventricular volumes and prevalence of nonviability in patients with coronary artery disease and severe left ventricular dysfunction Eur J Heart Fail, May 1, 2006; 8(3): 275 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chareonthaitawee, B. J. Gersh, P. A. Araoz, and R. J. Gibbons Revascularization in Severe Left Ventricular Dysfunction: The Role of Viability Testing J. Am. Coll. Cardiol., August 16, 2005; 46(4): 567 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J Fox, A P Fitzpatrick, and N C Davidson Optimisation of cardiac resynchronisation therapy: addressing the problem of "non-responders" Heart, August 1, 2005; 91(8): 1000 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Gibbons and P. A. Araoz The year in cardiac imaging J. Am. Coll. Cardiol., November 16, 2004; 44(10): 1937 - 1944. [Full Text] [PDF]
|
|
|
|
|
|
S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, S. Tange, T. Suzuki, and M. Kurabayashi Dobutamine Stress 99mTc-Tetrofosmin Quantitative Gated SPECT Predicts Improvement of Cardiac Function After Carvedilol Treatment in Patients with Dilated Cardiomyopathy J. Nucl. Med., November 1, 2004; 45(11): 1878 - 1884. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
